Correlation Between Candel Therapeutics and Indivior PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Indivior PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Indivior PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Indivior PLC Ordinary, you can compare the effects of market volatilities on Candel Therapeutics and Indivior PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Indivior PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Indivior PLC.

Diversification Opportunities for Candel Therapeutics and Indivior PLC

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Candel and Indivior is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Indivior PLC Ordinary in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indivior PLC Ordinary and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Indivior PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indivior PLC Ordinary has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Indivior PLC go up and down completely randomly.

Pair Corralation between Candel Therapeutics and Indivior PLC

Given the investment horizon of 90 days Candel Therapeutics is expected to generate 2.82 times less return on investment than Indivior PLC. In addition to that, Candel Therapeutics is 3.98 times more volatile than Indivior PLC Ordinary. It trades about 0.03 of its total potential returns per unit of risk. Indivior PLC Ordinary is currently generating about 0.3 per unit of volatility. If you would invest  1,051  in Indivior PLC Ordinary on September 12, 2024 and sell it today you would earn a total of  120.00  from holding Indivior PLC Ordinary or generate 11.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Candel Therapeutics  vs.  Indivior PLC Ordinary

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Indivior PLC Ordinary 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Indivior PLC Ordinary are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Indivior PLC showed solid returns over the last few months and may actually be approaching a breakup point.

Candel Therapeutics and Indivior PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and Indivior PLC

The main advantage of trading using opposite Candel Therapeutics and Indivior PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Indivior PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indivior PLC will offset losses from the drop in Indivior PLC's long position.
The idea behind Candel Therapeutics and Indivior PLC Ordinary pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities